Journal of Viral Hepatitis

Cover image for Journal of Viral Hepatitis

May 2002

Volume 9, Issue 3

Pages 157–241

  1. Review Article

    1. Top of page
    2. Review Article
    3. Original Articles
  2. Original Articles

    1. Top of page
    2. Review Article
    3. Original Articles
    1. Mapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins (pages 174–182)

      L. V. Olenina, L. I. Nikolaeva, B. N. Sobolev, N. P. Blokhina, A. I. Archakov and E. F. Kolesanova

      Version of Record online: 9 MAY 2002 | DOI: 10.1046/j.1365-2893.2002.00358.x

      • image
    2. Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment (pages 183–188)

      R. Zampino, A. Marrone, G. Cirillo, E. Miraglia Del Giudice, R. Utili, P. Karayiannis, T. J. Liang and G. Ruggiero

      Version of Record online: 9 MAY 2002 | DOI: 10.1046/j.1365-2893.2002.00347.x

      • image
    3. Matrix metalloproteinases and their inhibitors in acute viral hepatitis (pages 189–193)

      M. Koulentaki, V. Valatas, K. Xidakis, A. Kouroumalis, E. Petinaki, E. Castanas and E. Kouroumalis

      Version of Record online: 9 MAY 2002 | DOI: 10.1046/j.1365-2893.2002.00351.x

      • image
      • image
      • image
    4. Constrained genomic and conformational variability of the hypervariable region 1 of hepatitis C virus in chronically infected patients (pages 194–201)

      K. Hino, M. Korenaga, E. Orito, Y. Katoh, Y. Yamaguchi, F. Ren, A. Kitase, Y. Satoh, D. Fujiwara and K. Okita

      Version of Record online: 9 MAY 2002 | DOI: 10.1046/j.1365-2893.2002.00349.x

      • image
      • image
      • image
      • image
    5. Early detection of nonresponse to interferon plus ribavirin combination treatment of chronic hepatitis C (pages 202–207)

      F. J. Castro, J. I. Esteban, A. Juárez, S. Sauleda, L. Viladomiu, M. Martell, F. Moreno, H. Allende, R. Esteban and J. Guardia

      Version of Record online: 9 MAY 2002 | DOI: 10.1046/j.1365-2893.2002.00348.x

      • image
    6. Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion (pages 208–212)

      K. M. Lee, S. W. Cho, S. W. Kim, H. J. Kim, K. B. Hahm and J. H. Kim

      Version of Record online: 9 MAY 2002 | DOI: 10.1046/j.1365-2893.2002.00357.x

      • image
      • image
    7. Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue? (pages 221–228)

      A. B. Van Nunen, R. A. De Man, R. A. Heijtink, A. C. T. M. Vossen and S. W. Schalm

      Version of Record online: 9 MAY 2002 | DOI: 10.1046/j.1365-2893.2002.00337.x

      • image
      • image
      • image
    8. Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients (pages 229–234)

      J. J.-Y. Sung, H. L.-Y. Chan, M. L. Wong, C.-H. Tse, S. C.-H. Yuen, J. S.-L. Tam and N. W.-Y. Leung

      Version of Record online: 9 MAY 2002 | DOI: 10.1046/j.1365-2893.2002.00352.x

      • image
      • image
    9. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection (pages 235–241)

      J. Westin, L. M. Lagging, F. Spak, N. Aires, E. Svensson, M. Lindh, A. P. Dhillon, G. Norkrans and R. Wejstål

      Version of Record online: 9 MAY 2002 | DOI: 10.1046/j.1365-2893.2002.00356.x

      • image
      • image
      • image

SEARCH

SEARCH BY CITATION